August 31, 2016 4:26 AM ET

Capital Markets

Company Overview of Genome Ventures

Executive Profile

Marlen Jeraldovich Manasov

AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 9 different industries.

See Board Relationships
51--

Background

Mr. Marlen Jeraldovich Manasov serves as the Managing Director of UBS Securities CJSC. Mr. Manasov serves as Partner at Genome Ventures. He has been Sole Proprietor of Marlen Geraldovich Manasov since 2011. He serves as Chairman of OJSC RosTelecom and has been its Member of the Board of Directors since 2011. He has been a Member of the Board of Directors at OJSC Interdepartmental Analytical Center since 2011 and OJSC FosAgro-?herepovets since 2012. He has been a Director ...

Corporate Headquarters

7/1 Soymonovsky Passage
Moscow, -- --

Russia

Phone: 7 4956 39 93 54
Fax: --

Board Members Memberships

Independent Director, Member of Personnel & Remuneration Committee and Member of Strategy Committee
Member of the Board of Director
2007-Present
Director
2011-Present
Director, Chairman of Strategic Planning Committee and Member of Human Resources & Compensation Committee

Education

Unknown/Other Education 1990
Lomonosov Moscow State University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Genome Ventures, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.